Virtu Financial’s Cue Biopharma CUE Stock Holding History

Virtu Financial’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11K	Buy	+1,652	New	+$15.4K	﹤0.01%	1454
2025 Q4	–	Sell	-503	Closed	-$11K	–	1777
2025 Q3	$11K	Sell	503 -186	-27%	-$4.37K	﹤0.01%	1337
2025 Q2	$14K	Buy	+689	New	+$14.7K	﹤0.01%	1287
2025 Q1	–	Sell	-561	Closed	-$18K	–	1481
2024 Q4	$18K	Buy	+561	New	+$21.1K	﹤0.01%	1314
2023 Q3	–	Sell	-586	Closed	-$64K	–	1415
2023 Q2	$64K	Buy	+586	New	+$68.9K	﹤0.01%	1103
2021 Q3	–	Sell	-830	Closed	-$290K	–	1589
2021 Q2	$290K	Buy	+830	New	+$322K	0.03%	743
2018 Q2	–	Sell	-551	Closed	-$232K	–	2053
2018 Q1	$232K	Buy	+551	New	+$251K	0.01%	1247

Other funds holding CUE

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

GWMR

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

RSWM

Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

AWM

Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Virtu Financial's CUE Position: Q1 2026 in Review

Virtu Financial opened a new position in Cue Biopharma (CUE) in Q1 2026: 1,652 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #1454 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CUE as recently as Q3 2025.

Virtu Financial first reported a position in CUE in Q1 2018 and has held it in 7 quarters since. The position peaked at $290K in Q2 2021. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

Virtu Financial held 1,652 shares of Cue Biopharma worth $11K as of Q1 2026.
Cue Biopharma was a new Virtu Financial position in Q1 2026.
Cue Biopharma made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1454 holding.
Virtu Financial first reported a position in Cue Biopharma in Q1 2018 and has held it in 7 quarters since.
Virtu Financial's Cue Biopharma position peaked at $290K in Q2 2021.
55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.